drugset / Trial / NCT06577493
Effectiveness of Phenazopyridine for Pain Following Urodynamics
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of the study is to determine if taking phenazopyridine (AZO) at the time of urodynamic study testing will decrease pain experienced by patients after undergoing urodynamic testing.
Timeline
- Start
- 2024-12-17
- Primary completion
- 2025-11-24
- Completion
- 2026-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phenazopyridine | Small molecule | 199 mg | Oral |
Indications
No indication recorded.